Visit COVID-19 resources

[Skip to Content]

Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom – (Eye 31, 650 (April 2017))

13 April 2017

This news item is available to RCOphth members only, please log in below to access.

Members Login